In vivo tumouricidal effects of LAD-1 monoclonal antibody on murine RL-male-1 lymphoma mediated by enhanced phagocytosis

Clinical and Experimental Immunology

Volumn 141, Issue 1, 2005, Pages 54-61

  Ito, M ^a,b   Omoto, S ^a   Kato, Y ^c   Hayashi, T ^d   Mori, N ^b   Fujii, Yoichi R ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c YAMAGATA UNIVERSITY HOSPITAL   (Japan)

^d Tohoku Chuo Hospital   (Japan)

Author keywords

Antitumour; Fibronectin; Liver; Phagocytosis; T lymphoma

Indexed keywords

CASPASE INHIBITOR; CLODRONIC ACID; FIBRONECTIN RECEPTOR; LIPOSOME; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LAD 1; MONOCLONAL ANTIBODY LAD 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; LIVER CELL; LYMPHOMA CELL; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; SURVIVAL TIME; T CELL LYMPHOMA; TUMOR CELL DESTRUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL PROLIFERATION; COCULTURE TECHNIQUES; LIPOSOMES; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; LYMPHOMA, T-CELL; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHAGOCYTOSIS; PROPIDIUM; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 21344471093     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02809.x     Document Type: Article

References (30)

1. Gopal AK, Press OW. Clinical applications of anti-CD20 antibodies. J Lab Clin Med 1999; 134:445-50.
2. Cartron G, Dacheux L, Salles G et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood 2002; 99:754-8.
3. Manches O, Lui G, Chaperot L et al. In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas. Blood 2003; 101:949-54.
4. van der Kolk LE, Grillo-Lopez AJ, Baars JW et al. Complement activation plays a key role in the side-effects of rituximab treatment. Br J Haematol 2001; 115:807-11.
5. Harjunpaa A, Junnikkala S, Meri S. Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms. Scand J Immunol 2000; 51:634-41.
6. Cragg MS, Morgan SM, Chan HTC et al. Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts. Blood 2003; 101:1045-52.
7. Byrd JC, Kitada S, Flinn IW et al. The mechanism of tumour cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. Blood 2002; 99:1038-43.
8. Shan D, Ledbetter JA, Press OW. Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells. Cancer Immunol Immunother 2000; 48:673-83.
9. Mathas S, Rickers A, Bommert K et al. Anti-CD-20 and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways. Cancer Res 2000; 60:7170-6.
10. Clines RA, Towers TL, Presta LG, Ravetch JV. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumour targets. Nat Med 2000; 6:443-6.
11. Cragg MS, Glennie MJ. Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents. Blood 2004; 103:2738-43.
12. Stroeken PJM, van Rijthoven EAM, van der Valk MA, Roos E. Tageted distribution of the beta1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity. Cancer Res 1998; 58:1569-77.
13. Gazi MH, Ito M. Use of a novel fibronectin receptor for liver infiltration by a mouse lymphoma cell line RL-male-1. Cancer Res 1999; 59:1115-19.
14. Aoudjit F, Potworowski EF, Springer TA, St-Piere Y. Protection from lymphoma cell metastasis in ICAM-1 mutant mice: a posthoming event. J Immunol 1998; 161:2333-8.
15. Rocha M, Kruger A, Umansky V et al. Dynamic expression changes in vivo of adhesion and costimulatory molecules determines load and pattern of lymphoma liver metastasis. Clin Cancer Res 1996; 2:811-20.
16. Fujii Y, Kimura S, Arai S, Sendo F. In vivo antitumour effect of lymphokine-activated rodent polymorphonuclear leukocytes. Cancer Res 1987; 47:6000-5.
17. Yatabe Y, Oka K, Asai J et al. Poor correlation between clonal immunoglobulin gene rearrangement and immunoglobulin gene transcription in Hodgkin's disease. Am J Pathol 1996; 149:1351-61.
18. Otake K, Omoto S, Yamamoto T et al. HIV-1 Nef in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors. AIDS 2004; 18:189-98.
19. Vermes I, Haanen C, Steffens-Nakken H et al. A novel assay for apoptosis flow cytometric detection of phophatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J Immunol Meth 1995; 184:39-51.
20. van Rooijen N, Sanders A. Liposomal mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Meth 1994; 174:83-93.
21. Foghsgaard L, Wissing D, Mauch D et al. Cathepsin B acts as a dominant execution protease in tumour cell apoptosis induced by tumour necrosis factor. J Cell Biol 2001; 153:999-1009.
22. Ohshita T, Nikawa T, Towatari T et al. Effects of selective inhibition of cathepsin B and general inhibition of cysteine proteases on lysosomal proteolysis in rat liver in vitro and in vivo. Eur J Biochem 1992; 209:223-31.
23. Fadok VA, Voelker DR, Campbell PA et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148:2207-16.
24. Ren Y, Savill J. Apoptosis: the importance of being eaten. Cell Death Differ 1998; 5:563-8.
25. Scott RS, McMahon EJ, Pop SM et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001; 411:207-11.
26. Matsuoka S, Asano Y, Sano K et al. A novel type of cell death of lymphocytes induced by a monoclonal antibody without participation of complement. J Exp Med 1995; 181:2007-2015.
27. Bhat NM, Bieber MM, Stevenson FK et al. Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene encoded monoclonal antibodies. Clin Exp Immunol 1996; 105:183-90.
28. Zhang C, Xu Y, Gu J et al. A cell surface receptor defined by a mAb mediates a unique type of cell death similar to oncosis. Proc Natl Acad Sci USA 1998; 95:6290-5.
29. Pettersen RD, Bernard G, Olafsen MK et al. CD99 signals caspase independent T cell death. J Immunol 2001; 166:4931-42.
30. Kawai M, He L, Kawamura T et al. Chimeric human/murine monoclonal IgM antibodies to HIV-1 Nef antigen expressed on chronically infected cells. Microbiol Immunol 2003; 47:247-53.